IMVT
Immunovant Inc
NASDAQ: IMVT · HEALTHCARE · BIOTECHNOLOGY
$26.95
-0.15% today
Updated 2026-04-29
Market cap
$5.49B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.67
Dividend yield
—
52W range
$13 – $30
Volume
1.4M
Immunovant Inc (IMVT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-128.30M | — | $-28.55M | $-53.36M | $-83.33M | $-106.11M | $-188.19M | $-214.23M | $-375.87M |
| Capital expenditures | $52000.00 | $0.00 | $52000.00 | $31000.00 | $210000.00 | $254000.00 | $197000.00 | $360000.00 | $759000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.81M | — | $1.31M | $6.96M | $18.82M | $34.24M | $32.30M | $41.12M | $49.49M |
| Free cash flow | $-128.35M | — | $-28.60M | $-53.39M | $-83.54M | $-106.37M | $-188.39M | $-214.59M | $-376.63M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $299.57M | $93.76M | $-117.50M | — | — |